enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. Meningococcal vaccine - Wikipedia

    en.wikipedia.org/wiki/Meningococcal_vaccine

    Meningococcal vaccine refers to any vaccine used to prevent infection by Neisseria meningitidis. [9] Different versions are effective against some or all of the following types of meningococcus: A, B, C, W-135, and Y. [9] [10] The vaccines are between 85 and 100% effective for at least two years. [9]

  3. NmVac4-A/C/Y/W-135 - Wikipedia

    en.wikipedia.org/wiki/NmVac4-A/C/Y/W-135

    NmVac4-A/C/Y/W-135 is the commercial name for a polysaccharide vaccine that protects against meningococcal meningitis caused by Neisseria meningitidis, specifically the serotypes A, C, Y, and W-135. This vaccine is part of a broader group of meningococcal vaccines .

  4. Meningitis - Wikipedia

    en.wikipedia.org/wiki/Meningitis

    [3] [8] Meningitis can lead to serious long-term consequences such as deafness, epilepsy, hydrocephalus, or cognitive deficits, especially if not treated quickly. [2] [3] In 2019, meningitis was diagnosed in about 7.7 million people worldwide, [9] of whom 236,000 died, down from 433,000 deaths in 1990. [9]

  5. A ‘new turning point’: Patients could soon have a new shot to ...

    www.aol.com/turning-point-patients-could-soon...

    Pfizer’s new meningococcal vaccine, Penbraya, protects against five kinds of bacteria and could soon be an option that offers people broad protection from meningococcal disease with fewer shots.

  6. Penbraya - Wikipedia

    en.wikipedia.org/wiki/Penbraya

    Penbraya is a pentavalent conjugate vaccine developed by Pfizer for the prevention of invasive meningococcal disease in people 10 through 25 years of age. [4] Invasive meningococcal disease, caused by the bacterium Neisseria meningitidis, can lead to serious conditions such as meningitis (inflammation of the brain and spinal cord lining) and sepsis. [5]

  7. Neisseria meningitidis - Wikipedia

    en.wikipedia.org/wiki/Neisseria_meningitidis

    A meningococcal polysaccharide vaccine (MPSV4) has been available since the 1970s and is the only meningococcal vaccine licensed for people older than 55. MPSV4 may be used in people 2–55 years old if the MCV4 vaccines are not available or contraindicated. Two meningococcal conjugate vaccines (MCV4) are licensed for use in the U.S. The first ...

  8. World Cup 2014 - Germany vs. Argentina - The Huffington Post

    data.huffingtonpost.com/2014/world-cup/matches/...

    The 2014 World Cup in Brazil has begun. Check HuffPost's World Cup dashboard throughout the tournament for standings, schedules, and detailed summaries of each match.

  9. Bruno Mars Jokes He'll 'Be Out of Debt in No Time' While ...

    www.aol.com/bruno-mars-jokes-hell-debt-210000257...

    Bruno Mars won't be dropping any 24K magic any time soon.. The “Die with a Smile” singer, 39, poked fun at since-denied rumors that he’s in gambling debt in a cheeky post on Instagram on ...